<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-------------------------------------------------------
SCHEDULE 13G
(RULE 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13D-1(b) AND (c) AND AMENDMENTS THERETO FILED
PURSUANT TO 13d-2(b)
(AMENDMENT NO. __)(1)
NOVAMED EYECARE, INC.
- --------------------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK
- --------------------------------------------------------------------------------
(Title of Class of Securities)
669865107
- --------------------------------------------------------------------------------
(CUSIP Number)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
/ / Rule 13d-1(b)
/ / Rule 13d-1(c)
/X/ Rule 13-1(d)
- -------------------------
(1) The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class
of securities, and for any subsequent amendment containing information
which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of
that section of the Act but shall be subject to all other provisions of
the Act (however, see the Notes).
<PAGE>
CUSIP NO. 13G Page 2 of 9 Pages
- -------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
SIERRA VENTURES V, A CALIFORNIA LIMITED PARTNERSHIP
("SIERRA V") 94-3222153
- -------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER (a) / / (b) /X/
OF A GROUP*
- -------------------------------------------------------------------------------
(3) SEC USE ONLY
- -------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
CALIFORNIA LIMITED PARTNERSHIP
- -------------------------------------------------------------------------------
NUMBER OF SHARES (5) SOLE VOTING POWER -0-
BENEFICIALLY
OWNED BY --------------------------------------------------
EACH REPORTING (6) SHARED VOTING POWER 2,366,722
PERSON WITH:
--------------------------------------------------
(7) SOLE DISPOSITIVE POWER -0-
--------------------------------------------------
(8) SHARED DISPOSITIVE POWER 2,366,722
- -------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,366,722
- -------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
EXCLUDES CERTAIN SHARES* / /
- -------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 9.8%
- -------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON* PN
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP NO. 13G Page 3 of 9 Pages
- -------------------------------------------------------------------------------
(1) NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
SV ASSOCIATES V, L.P. ("SV ASSOCIATES") 94-3222154
- -------------------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER (a) / / (b) /X/
OF A GROUP*
- -------------------------------------------------------------------------------
(3) SEC USE ONLY
- -------------------------------------------------------------------------------
(4) CITIZENSHIP OR PLACE OF ORGANIZATION
CALIFORNIA LIMITED PARTNERSHIP
- -------------------------------------------------------------------------------
NUMBER OF SHARES (5) SOLE VOTING POWER -0-
BENEFICIALLY
OWNED BY --------------------------------------------------
EACH REPORTING (6) SHARED VOTING POWER 2,366,722
PERSON WITH:
--------------------------------------------------
(7) SOLE DISPOSITIVE POWER -0-
--------------------------------------------------
(8) SHARED DISPOSITIVE POWER 2,366,722
- -------------------------------------------------------------------------------
(9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,366,722
- -------------------------------------------------------------------------------
(10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) / /
EXCLUDES CERTAIN SHARES*
- -------------------------------------------------------------------------------
(11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 9.8%
- -------------------------------------------------------------------------------
(12) TYPE OF REPORTING PERSON* PN
- -------------------------------------------------------------------------------
<PAGE>
Page 4 of 9 Pages
ITEM 1(a) NAME OF ISSUER:
Novamed Eyecare, Inc.
ITEM 1(b) ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
980 North Michigan Ave., Suite 1620
Chicago, IL 60611
ITEM 2(a) NAME OF PERSON FILING:
This statement is being filed by SV Associates V, L.P., a
California Limited Partnership ("SV Associates") whose
principal business is 3000 Sand Hill Road, Building Four,
Suite 210, Menlo Park, California 94025. SV Associates is
general partner to Sierra Ventures V, a California Limited
Partnership ("Sierra V"). With respect to SV Associates, this
amended statement relates only to SV Associates' indirect,
beneficial ownership of shares of Common Stock of Novamed
Eyecare, Inc. (the "Shares"). The Shares are held directly by
Sierra V, and SV Associates does not directly or otherwise
hold any Shares. Management of the Business affairs of SV
Associates, including decisions respecting disposition and/or
voting of the Shares, is by majority decision of the general
partners of SV Associates listed on Exhibit B hereto. Each
individual general partner disclaims beneficial ownership of
the Shares.
ITEM 2(b) ADDRESS OF PRINCIPAL BUSINESS OFFICES OR, IF NONE, RESIDENCE:
See Above.
ITEM 2(c) CITIZENSHIP
See Above
ITEM 2(d) TITLE OF CLASS OF SECURITIES:
Common Stock
ITEM 2(e) CUSIP NUMBER:
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13d-1(b) OR
13d-2(b), CHECK WHETHER THE PERSON FILING IS A:
Not applicable.
ITEM 4. OWNERSHIP.
Please see Rows 5-11 of cover pages.
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.
Not applicable.
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER
PERSON.
<PAGE>
Page 5 of 9 Pages
Under certain circumstances set forth in the Limited Partnership
agreements of Sierra V and SV Associates, the general and
limited partners of such entities may have the right to receive
dividends from, or the proceeds from the sale of shares of Common
Stock of Novamed Eyecare, Inc. held by such entity. No such
partner's rights relate to more than five percent of the
class.
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH
ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING
COMPANY.
Not applicable.
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.
Not applicable.
ITEM 9. NOTICE OF DISSOLUTION OF GROUP.
Not applicable.
ITEM 10. CERTIFICATION.
Not applicable.
<PAGE>
Page 6 of 9 Pages
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I
certify that that information set forth in this statement is true, complete and
correct.
February 14, 2000
SV ASSOCIATES V, L.P.
By: /s/ Peter C. Wendell
------------------------------
Peter C. Wendell
General Partner
SIERRA VENTURES V, A
CALIFORNIA LIMITED
PARTNERSHIP
By SV Associates V, L.P., its
General Partner
By: /s/ Peter C. Wendell
------------------------------
Peter C. Wendell
General Partner
<PAGE>
Page 7 of 9 Pages
EXHIBIT INDEX
Found on
Sequentially
Exhibit Numbered Page
------- -------------
Exhibit A: Agreement of Joint Filing 8
Exhibit B: List of General Partners of SV Associates V, L.P. 9
<PAGE>
Page 8 of 9 Pages
EXHIBIT A
AGREEMENT OF JOINT FILING
The undersigned hereby agree that they are filing jointly pursuant to
Rule 13d-1 of the Act the statement dated February 14, 2000, containing the
information required by Schedule 13G, for the Shares of the Common Stock of
Novamed Eyecare, Inc. held by Sierra Ventures V, a California Limited
Partnership.
February 14, 2000
SV ASSOCIATES V, L.P.
By: /s/ Peter C. Wendell
------------------------------
Peter C. Wendell
General Partner
SIERRA VENTURES V, A
CALIFORNIA LIMITED
PARTNERSHIP
By SV Associates V, L.P., its
General Partner
By: /s/ Peter C. Wendell
------------------------------
Peter C. Wendell
General Partner
<PAGE>
Page 9 of 9 Pages
EXHIBIT B
GENERAL PARTNERS OF SV ASSOCIATES V, L.P.
Set forth below, with respect to each general partners of SV
Associates V, L.P. is the following: (a) name; (b) business address and (c)
citizenship.
1. (a) Peter C. Wendell
(b) c/o Sierra Ventures
3000 Sand Hill Road
Building Four, Suite 210
Menlo Park, CA 94025
(c) United States Citizen
2. (a) Jeffrey M. Drazan
(b) c/o Sierra Ventures
3000 Sand Hill Road
Building Four, Suite 210
Menlo Park, CA 94025
(c) United States Citizen
